Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (28)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Tavaniotou, A.
Right arrow Articles by Devroey, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tavaniotou, A.
Right arrow Articles by Devroey, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction Update, Vol.6, No.2 pp.139-148, 2000
© European Society of Human Reproduction and Embryology 2000; all rights reserved

Comparison between different routes of progesterone administration as luteal phase support in infertility treatments

A. Tavaniotoubihdhggb, J. Smitzbihdhggb, C. Bourgainbihgdcfi and P. Devroeybihdhggb,1

bihdhggb Centre for Reproductive Medicine and bihgdcfi Department of Pathology, Dutch-Speaking Free University of Brussels, Brussels, Belgium

Received on July 20, 1999; accepted on January 12, 2000

Abstract

Different routes of natural progesterone supplementation have been tried as luteal phase support in infertility treatments. Orally administered progesterone is rapidly metabolized in the gastrointestinal tract and its use has proved to be inferior to i.m. and vaginal routes. Progesterone i.m. achieves serum progesterone values that are within the range of luteal phase and results in sufficient secretory transformation of the endometrium and satisfactory pregnancy rates. The comparison between i.m. and vaginal progesterone has led to controversial results as regards the superiority of one or the other in inducing secretory endometrial transformation. However, there is increasing evidence in the literature to favour the use of vaginal progesterone. Vaginally administered progesterone achieves adequate endometrial secretory transformation but its pharmacokinetic properties are greatly dependent on the formulation used. After vaginal progesterone application, discrepancies have been detected between serum progesterone values and histological endometrial features. Vaginally administered progesterone results in adequate secretory endometrial transformation, despite serum progesterone values lower than those observed after i.m. administration, even if they are lower than those observed during the luteal phase of the natural cycle. This discrepancy is indicative of the first uterine pass effect and therefore of a better bioavailability of progesterone in the uterus, with minimal systematic undesirable effects.

Key words: In-vitro fertilization/ / luteal phase/ / oocyte donation/ / progesterone supplementation


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am J Health Syst PharmHome page
J. d. Neves, B. Santos, B. Teixeira, G. Dias, T. Cunha, and J. Brochado
Vaginal drug administration in the hospital setting
Am. J. Health Syst. Pharm., February 1, 2008; 65(3): 254 - 259.
[Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
H.M. Fatemi, B. Popovic-Todorovic, E. Papanikolaou, P. Donoso, and P. Devroey
An update of luteal phase support in stimulated IVF cycles
Hum. Reprod. Update, November 1, 2007; 13(6): 581 - 590.
[Abstract] [Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
S. L. Carmichael, G. M. Shaw, C. Laurent, M. S. Croughan, R. S. Olney, E. J. Lammer, and for the National Birth Defects Prevention Study
Maternal Progestin Intake and Risk of Hypospadias
Arch Pediatr Adolesc Med, October 1, 2005; 159(10): 957 - 962.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
Y. Bouckaert, F. Robert, Y. Englert, D. De Backer, P. De Vuyst, and A. Delbaere
Acute eosinophilic pneumonia associated with intramuscular administration of progesterone as luteal phase support after IVF: Case report
Hum. Reprod., August 1, 2004; 19(8): 1806 - 1810.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
E.A. Pritts and A.K. Atwood
Luteal phase support in infertility treatment: a meta-analysis of the randomized trials
Hum. Reprod., September 1, 2002; 17(9): 2287 - 2299.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.